We are live on ! Find out more
ZSPH

ZS PHARMA INC COMS TK (DE)
ZSPH

Delisted

ZSPH was delisted on the 16th of December, 2015.

Back to rankings

65 hedge funds and large institutions have $293M invested in ZS PHARMA INC COMS TK (DE) in 2014 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,532% more capital invested

Capital invested by funds: $18M → $293M (+$275M)

713% more funds holding

Funds holding: 8 → 65 (+57)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
65
Holders Change
+57
Holders Change %
+712.5%
% of All Funds
1.89%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
57
Increased
3
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$41.7M
2
PHS
PFM Health Sciences
California
+$24.1M
3
JHIU
Janus Henderson Investors US
Colorado
+$20.4M
4
RCM
RA Capital Management
Massachusetts
+$18.7M
5
NHAS
Novo Holdings A/S
Denmark
+$16.7M

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.9M
2
WSA
Wall Street Associates
California
-$549K
3
GGHC
Gilder Gagnon Howe & Co
New York
-$242K
4
Citadel Advisors
Citadel Advisors
Florida
-$121K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$49.5M +$41.7M +1,261,561 New
PHS
2
PFM Health Sciences
California
$28.6M +$24.1M +729,044 New
JHIU
3
Janus Henderson Investors US
Colorado
$24.2M +$20.4M +618,071 New
RCM
4
RA Capital Management
Massachusetts
$22.1M +$18.7M +564,483 New
NHAS
5
Novo Holdings A/S
Denmark
$19.9M +$16.7M +506,730 New
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$19.4M +$16.3M +493,910 New
RG
7
Redmile Group
California
$18.6M +$15.7M +474,132 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$15.4M +$12.9M +391,800 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$12.9M +$10.9M +329,223 New
BFA
10
BlackRock Fund Advisors
California
$5.96M +$5.02M +151,940 New
EA
11
Emerald Advisers
Pennsylvania
$5.9M +$1.27M +38,360 +34%
WSA
12
Wall Street Associates
California
$5.63M -$549K -16,600 -10%
EMFAT
13
Emerald Mutual Fund Advisers Trust
Pennsylvania
$5.34M +$1.45M +43,954 +48%
Asset Management One
14
Asset Management One
Japan
$3.99M +$3.35M +101,461 New
VM
15
VHCP Management
New York
$3.92M – – –
Jennison Associates
16
Jennison Associates
New York
$3.82M +$3.22M +97,292 New
RSCM
17
Rock Springs Capital Management
Maryland
$3.61M +$3.04M +92,000 New
GTC
18
Ghost Tree Capital
New York
$3.33M +$2.81M +85,000 New
JP Morgan Chase
19
JP Morgan Chase
New York
$2.9M +$2.44M +73,975 New
WRF
20
Waddell & Reed Financial
Kansas
$2.44M +$2.05M +62,120 New
BIT
21
BlackRock Institutional Trust
California
$2.21M +$1.86M +56,253 New
State Street
22
State Street
Massachusetts
$2.21M +$1.86M +56,200 New
VAM
23
Visium Asset Management
New York
$2.16M +$1.82M +55,011 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$2.02M +$1.7M +51,484 New
CAM
25
Cormorant Asset Management
Massachusetts
$1.96M +$1.65M +50,000 New
1
2 3

ZSPH Hedge Fund Activity: Q3 2014 in Review

65 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ZS PHARMA INC COMS TK (DE) (ZSPH) for Q3 2014, worth a combined $293M — up 1,532% from $18M a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new ZSPH positions and 0 closed out — a net gain of 57 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $41.7M. The largest seller was Alyeska Investment Group, cutting an estimated $2.9M.

  • 65 institutional investors held ZS PHARMA INC COMS TK (DE) (ZSPH) as of Q3 2014, up from 8 in Q2 2014.
  • Funds reported $293M of ZS PHARMA INC COMS TK (DE) stock for Q3 2014, up 1,532% quarter-over-quarter.
  • 57 funds opened new ZS PHARMA INC COMS TK (DE) positions in Q3 2014 and 0 closed out, a net change of +57 holders.
  • The largest ZS PHARMA INC COMS TK (DE) buyer in Q3 2014 was Fidelity Investments, an estimated $41.7M added.
  • The largest ZS PHARMA INC COMS TK (DE) seller in Q3 2014 was Alyeska Investment Group, an estimated $2.9M sold.

Based on aggregated 13F filings for Q3 2014.